- Home
- LQDA vs ZD Comparison
LQDA vs ZD Comparison
Compare LQDA & ZD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LQDA
- ZD
- Stock Information
- Founded
- LQDA 2004
- ZD 1995
- Country
- LQDA United States
- ZD United States
- Employees
- LQDA N/A
- ZD N/A
- Industry
- LQDA Biotechnology: Pharmaceutical Preparations
- ZD Advertising
- Sector
- LQDA Health Care
- ZD Consumer Discretionary
- Exchange
- LQDA Nasdaq
- ZD Nasdaq
- Market Cap
- LQDA 1.3B
- ZD 1.4B
- IPO Year
- LQDA 2018
- ZD 1999
- Fundamental
- Price
- LQDA $13.17
- ZD $31.43
- Analyst Decision
- LQDA Strong Buy
- ZD Hold
- Analyst Count
- LQDA 9
- ZD 6
- Target Price
- LQDA $27.67
- ZD $49.67
- AVG Volume (30 Days)
- LQDA 3.0M
- ZD 484.1K
- Earning Date
- LQDA 08-06-2025
- ZD 08-06-2025
- Dividend Yield
- LQDA N/A
- ZD N/A
- EPS Growth
- LQDA N/A
- ZD 36.58
- EPS
- LQDA N/A
- ZD 1.76
- Revenue
- LQDA $14,144,000.00
- ZD $1,415,839,000.00
- Revenue This Year
- LQDA $185.38
- ZD $7.37
- Revenue Next Year
- LQDA $350.95
- ZD $3.65
- P/E Ratio
- LQDA N/A
- ZD $18.05
- Revenue Growth
- LQDA N/A
- ZD 3.24
- 52 Week Low
- LQDA $8.26
- ZD $29.15
- 52 Week High
- LQDA $19.41
- ZD $60.62
- Technical
- Relative Strength Index (RSI)
- LQDA 36.80
- ZD 44.57
- Support Level
- LQDA $13.60
- ZD $30.62
- Resistance Level
- LQDA $14.63
- ZD $32.44
- Average True Range (ATR)
- LQDA 0.96
- ZD 1.28
- MACD
- LQDA -0.40
- ZD -0.11
- Stochastic Oscillator
- LQDA 0.46
- ZD 18.33
About LQDA Liquidia Corporation
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.
About ZD Ziff Davis Inc.
Ziff Davis Inc is a focused digital media and internet company whose portfolio includes brands in technology, entertainment, shopping, health, cybersecurity, and martech. It has two reportable segments: Digital Media and Cybersecurity and Martech. The company's brands include Mashable, Ookla, Offers.com, IGN, and VPN among others. The majority of revenue is generated from Digital Media.